Suchergebnisse - "Halvorsen, Sigrun"

PubPharm (92)

1

Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease : EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia

enthalten in: Cardiovascular diabetology | 2023

von Vistisen, D. | Carstensen, B. | Elisabetta, P. | +54

2

European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care

enthalten in: European heart journal. Quality of care & clinical outcomes | 2023

von Gencer, B. | Gale, C. | Aktaa, S. | +13

3

The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition

enthalten in: Communications biology | 2022

von van der Meer, D. | Gurholt, T. | Sønderby, I. | +15

4

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

enthalten in: Circulation | 2022

von Hagström, E. | Steg, P. | Szarek, M. | +117

CommentIn: Circulation. 2022 Aug 30;146(9):673-675. - PMID 36037269

5

Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants : a Norwegian population based study

enthalten in: BMC primary care | 2022

von Halvorsen, S. | Smith, J. | Söderdahl, F. | +4

6

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation : a Scandinavian population-based cohort study

enthalten in: European heart journal. Quality of care & clinical outcomes | 2022

von Halvorsen, S. | Johnsen, S. | Madsen, M. | +9

7

Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway

enthalten in: European heart journal. Cardiovascular pharmacotherapy | 2022

von Jortveit, J. | Pripp, A. | Halvorsen, S.

8

Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke : A Post Hoc Analysis From the AUGUSTUS Trial

enthalten in: JAMA cardiology | 2022

von Bahit, M. | Vora, A. | Li, Z. | +15

9

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic : part 2-care pathways, treatment, and follow-up

enthalten in: Cardiovascular research | 2022

von Task Force for the management of COVID-19 of the European Society of Cardiology | Baigent, C. | Windecker, S. | +65

10

Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction : novel insights from four national European continuous real-world registries

enthalten in: European heart journal. Quality of care & clinical outcomes | 2022

von Edfors, R. | Jernberg, T. | Lewinter, C. | +12

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]